These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5515015)

  • 41. [Coronary therapy with Nitro-Sandolanid].
    Toker Y
    Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 43. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
    Musial W; Tracz W; Krzemińska-Pakula M
    Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
    [No Abstract]   [Full Text] [Related]  

  • 44. [A new beta-blockader, LB-46 (Visken): electrocardiographic control of its therapeutic action in angina patients].
    Saner R
    Therapie; 1970; 25(2):393-501. PubMed ID: 4403159
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical studies on the use of beta blocking agents in cardiac arrhythmias].
    Ravera M
    Minerva Cardioangiol; 1969 Apr; 17(4):237-41. PubMed ID: 5404809
    [No Abstract]   [Full Text] [Related]  

  • 46. [Positive and negative effects of beta-adrenergic blocking in angina pectoris. (Indications on the contemporary use of nitroglycerin and aminophylline)].
    Starcich R; Barbaresi F; Volta G; Pavarani A
    Minerva Cardioangiol; 1967 Dec; 15(12):835-43. PubMed ID: 4975623
    [No Abstract]   [Full Text] [Related]  

  • 47. Exercise performance and electrocardiographic changes as indices of effect of long-acting nitrates in angina pectoris.
    Abrahamsen AM; Kiil F
    Br Med J; 1966 Feb; 1(5485):456-8. PubMed ID: 5902683
    [No Abstract]   [Full Text] [Related]  

  • 48. [The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
    Hagel H
    Fortschr Med; 1981 Nov; 99(41):1714-7. PubMed ID: 7319440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Variant form of angina pectoris: a case report].
    Hwang YS
    Taiwan Yi Xue Hui Za Zhi; 1974 Aug; 73(8):466-70. PubMed ID: 4530037
    [No Abstract]   [Full Text] [Related]  

  • 50. [Combination therapy of angina pectoris vera with coronary active substances and Faustan].
    Nossing R; Gruber G; Schmidt P
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):589-91. PubMed ID: 5000186
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical use of the butydrine-pentaetythrite association].
    Ravera M
    Minerva Med; 1968 Oct; 59(86):4561-5. PubMed ID: 5697129
    [No Abstract]   [Full Text] [Related]  

  • 52. Is Peritrate life-sustaining?
    Med Lett Drugs Ther; 1966 Jan; 8(2):5-7. PubMed ID: 5324990
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
    Volta G; Pavarani A; Barbaresi F; Starcich R
    G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity.
    Amsterdam EA; Lee G; Awan NA; Low R; Mason DT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2443-6. PubMed ID: 7422533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Angina pectoris].
    Vagueiro MC
    Minerva Med; 1976 Dec; 67(61):4045-51. PubMed ID: 826855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The treatment of angina pectoris. 1].
    Baedeker W
    Med Klin; 1970 Oct; 65(43):1893-6. PubMed ID: 4990934
    [No Abstract]   [Full Text] [Related]  

  • 57. [Adrenergic beta-receptor blocking agents in the treatment of cardiothyreosis (arrhythmias, angina pectoris)].
    Popovici D
    Stud Cercet Endocrinol; 1969; 20(1):63-74. PubMed ID: 5343647
    [No Abstract]   [Full Text] [Related]  

  • 58. [The beta-blocking agents in clinically silent cardiopathies in patients with depressive syndromes].
    De Matteis D
    Minerva Med; 1969 Jan; 60(5):128-39. PubMed ID: 5776761
    [No Abstract]   [Full Text] [Related]  

  • 59. [Paradoxal reaction to beta-adrenergic blocking therapy of coronary angina].
    Dal Palù C; Gasparotto G; Stritoni P
    Boll Soc Ital Cardiol; 1967; 12(2):104-8. PubMed ID: 5606862
    [No Abstract]   [Full Text] [Related]  

  • 60. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.